New England Biolabs

T7 Endonuclease I

#M0302S

70
Citing papers
1.8k
Combined citations
Supplier page Find this product

Research areas

CRISPR and Genetic Engineering20Genomics and Phylogenetic Studies8Chromosomal and Genetic Variations7RNA Research and Splicing7Genetics and Neurodevelopmental Disorders6Plant Virus Research Studies6Bacteriophages and microbial interactions6Advanced biosensing and bioanalysis techniques6

Papers citing this product

1
Decoding myofibroblast origins in human kidney fibrosis
Nature·2020·728 cit.·DOI
2
CRISPR/Cas9-mediated genome editing efficiently creates specific mutations at multiple loci using one sgRNA in Brassica napus
Scientific Reports·2017·200 cit.·DOI
3
Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies
Nucleic Acids Research·2015·151 cit.·DOI
4
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
Journal of Clinical Investigation·2014·124 cit.·DOI
5
CRISPR/Cas9‑mediated cervical cancer treatment targeting human papillomavirus E6
Oncology Letters·2018·108 cit.·DOI
6
NanoAmpli-Seq: a workflow for amplicon sequencing for mixed microbial communities on the nanopore sequencing platform
GigaScience·2018·99 cit.·DOI
7
An anti-ACVR1 antibody exacerbates heterotopic ossification by fibro-adipogenic progenitors in fibrodysplasia ossificans progressiva mice
Journal of Clinical Investigation·2022·41 cit.·DOI
8
CHRAC/ACF contribute to the repressive ground state of chromatin
Life Science Alliance·2018·37 cit.·DOI
9
Novel impact of the DNMT3A R882H mutation on GSH metabolism in a K562 cell model established by TALENs
Oncotarget·2017·29 cit.·DOI
10
Method for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial Cells
Scientific Reports·2017·28 cit.·DOI

Similar products

ProductVendorPricePapers
T7 Endonuclease INew England Biolabs—33